Kenneth Moch

President & CEO @ Cognition Therapeutics

Found 2 valid emails:

Cognition Therapeutics

United States
11 - 50 employees
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.

SalesQL reveals any person's emails directly from Google Chrome: